Telecom Signaling Industry News

TMCNet:  Research and Markets: Osteoporosis - Pipeline Review, H1 2014: 60 Companies and 94 Drugs Profiled

[May 07, 2014]

Research and Markets: Osteoporosis - Pipeline Review, H1 2014: 60 Companies and 94 Drugs Profiled

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Osteoporosis - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoporosis and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sitesand industry-specific third party sources.

Companies Involved:

  • Affectis Pharmaceuticals AG
  • Alethia Biotherapeutics Inc.
  • Alkem Laboratories Ltd.
  • Amgen Astellas BioPharma K.K.
  • Amgen Inc.
  • Amura Holdings Ltd.
  • Asahi Kasei Pharma Corp.
  • Astellas Pharma Inc.
  • Ausio Pharmaceuticals, LLC
  • Azelon Pharmaceuticals Inc.
  • B&C Biopharm
  • Biodel Inc.
  • Biolo ElexoPharm GmbH
  • Bone Medical Limited
  • Bone Therapeutics SA
  • Calzada Limited
  • CardioVascular BioTherapeutics, Inc.
  • Centre de Regulacio Genomica
  • Chugai Pharmaceutical Co., Ltd.
  • Shenogen Pharma Group Ltd.
  • Siena Biotech S.p.A.
  • TSRL, Inc.
  • Takeda Pharmaceutical Company Limited
  • Uni-Bio Science Group Ltd.
  • Ventria Bioscience
  • Wroclawskie Centrum Badan EIT+ Sp. z o.o.
  • Zealand Pharma A/S
  • Zosano Pharma, Inc.
  • Zydus Cadila Healthcare Limited

Drug Profiles:

  • bazedoxifene acetate
  • denosumab
  • romosozumab
  • odanacatib
  • BA-058
  • zoledronic acid
  • ibandronate sodium
  • estrone sodium sulfate + (levonorgestrel + Ethinyl Estradiol) + prasterone
  • teriparatide
  • COVOP-77
  • E-4
  • teriparatide
  • calcitonin
  • PHN-031
  • teriparatide
  • teriparatide ZP Patch
  • alendronate sodium
  • DP-001
  • blosozumab
  • ES-1
  • AUS-131
  • IMD-2560
  • MIV-711
  • DW-1350
  • ZYPH-0907
  • OCT-1547
  • teriparatide
  • CDRI-99/373
  • VEN-130

For more information visit

[ Back To Telecom Signaling's Homepage ]

Featured Events

5G NA Signaling Day

November 14-16, 2016
Sheraton Dallas, Dallas, TX

Featured Webcasts

Securing The Signaling Interconnect: Oracle's Perspective On Recent Security Events

Today's telecommunications landscape is changing rapidly, and the "institution" of trust between networks that has been assumed over the decades is no longer relevant. We are now hearing of vulnerabilities in CSP interconnection points that have been known ...

Applications of Wi-Fi Calling

With all of the discussion about faster data access and richer content, it could be assumed that voice services no longer play an important role in the business model of the communications service provider. Join ReThink Technologies Research and Oracle Communications as we explore ...

Featured Whitepapers

Oracle Communications Diameter Signaling Router Main Differentiators

Diameter is the protocol used by network elements in LTE and 3G networks to enable and monetize services, such as voice, video and data. Diameter enables revenue-generating data services; including tiered data plans, loyalty programs, application specific QoS, content provider and Internet of Things (IoT) solutions ...

Multi-Layer Security Protection for Signaling Networks

The sanctity of mobile operators' networks and brands will depend greatly on their ability to deliver QoS guarantees to roaming and interconnect partners, while simultaneously protecting increasingly multimedia-savvy and socially connected ...

Featured Datasheets

Oracle Communications Diameter Signaling Router

Centralizing Diameter routing with cloud deployable Oracle Communications Diameter Signaling Router creates a secure signaling architecture that reduces the cost and complexity of the core network and enables elastic growth, interoperability and rapid introduction ...

Oracle Communications Mobile Security Gateway

The Oracle Communications Mobile Security Gateway is a high performance gateway that allows the Communications Service Provider (CSP) to cost effectively expand network coverage and increase capacity by incorporating Heterogeneous ...

Oracle Communications Evolved Communications Application Server

As service providers drive their networks toward an all-IP and virtualized state, they require the means to design and deliver compelling high definition voice, video and multimedia offers via Voice over LTE (VoLTE) and Voice over WiFi (VoWiFi) ...

Featured Infographic